Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19

A novel coronavirus, later named SARS-CoV-2, was first reported in China in December 2019 and subsequently widely identified in the United States, Japan, South Korea, France, India, and other countries. The disease caused by SARS-CoV-2 infection was called COVID-19. The high fatality and morbidity r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Li, Dai, Lijun, Zhang, Xingyu, Zhang, Zhaohui, Zhang, Zhentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pharmaceutical Society of Korea 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395211/
https://www.ncbi.nlm.nih.gov/pubmed/32740801
http://dx.doi.org/10.1007/s12272-020-01258-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395211/
https://www.ncbi.nlm.nih.gov/pubmed/32740801
http://dx.doi.org/10.1007/s12272-020-01258-7

Ejemplares similares